07:22 EDT Twist Bioscience (TWST) expects to achieve adjusted EBITDA breakeven for Q4
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TWST:
- Twist Bioscience reports Q2 EPS (71c) vs. (66c) last year
- Twist Bioscience raises FY26 revenue view $442M-$447M from $435M-$440M
- TWST Upcoming Earnings Report: What to Expect?
- Twist Bioscience price target raised to $55 from $50 at Barclays
- Twist Bioscience price target raised to $56 from $52 at Evercore ISI